Boston Scientific's Recent Performance: What Investors Need to Know

Boston Scientific (BSX) shares fell 2% to $68.15, lagging the S&P 500's 0.37% loss. The medical device manufacturer's earnings per share are projected to be $0.8, a 6.67% increase from the same quarter last year, and revenue is expected to be $5.19 billion, up 11.22% YoY. The full-year Zacks Consensus Estimates are calling for earnings of $3.45 per share and revenue of $22.3 billion. The Zacks Rank is #3 (Hold), and the Forward P/E ratio is 20.14, compared to the average Forward P/E of 18.65 in the industry.